Navigation Links
Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits
Date:2/19/2011

010, Peter Kerrane, Global Head of Mergers & Acquisitions of Novartis, contacted representatives of Barclays regarding participating in the ongoing process. On November 29, 2010, Novartis International and the Company executed the Confidentiality Agreement."

The nineteenth paragraph under the heading titled "Background of Offer" is hereby amended and restated as follows:

"On December 6, 2010, the Company's board of directors met with legal and financial advisors and the management of the Company to discuss the status of discussions with the interested parties and the range of strategic options available to the Company.  As of the date of this meeting, Barclays had contacted 10 potential bidders (including Novartis), 9 of whom were clinical laboratory or diagnostic companies and 1 financial party that owned a diagnostic laboratory business.  Because Novartis expressed interest in entering the process, the Company's board of directors asked Barclays whether there were other large pharmaceutical companies with [oncology] diagnostic testing products that might also have an interest in acquiring the Company.  Following the meeting, Barclays contacted four parties with this profile and none of them expressed any interest in discussing a strategic transaction with the Company."

The third paragraph under the heading titled "Opinion of Barclays - Selected Precedent Transaction Analysis" is hereby amended and restated as follows:

"The reasons for and the circumstances surrounding each of the selected precedent transactions analyzed were diverse and there are inherent differences in the business, operations, financial conditions and prospects of the Company and the companies included in the selected precedent transaction analysis. Accordingly, Barclays believed that a purely quantitative selected precedent transaction analysis would not be particularly meaningful in the cont
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting
2. Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results
3. Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009
4. Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
5. Genoptix, Inc. to Announce First Quarter 2010 Financial Results
6. Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference
7. Genoptix Ranked 41st Fastest-Growing Company in North America on Deloittes 2010 Technology Fast 500™
8. Genoptix Reports Operating Results for the Third Quarter and First Nine Months of 2010
9. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
10. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
11. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015 BRH ... filing of a Pre-Marketing Notification Application (510k) with the ... Wound Management System. BRH Medical expects feedback from the ... US market with BRH-A2 following FDA pre-market clearance. Additional ... Motti Oderberg , CEO for BRH Medical, commented, ...
(Date:4/27/2015)... BANGALORE, India , April 27, 2015 ... Granted a Process Patent by the State Intellectual Property Office ... Cell Drug Based on Pooling Technology  - A ... Limb Ischemia (CLI)    - About 20% of ... the Prevalence in Women is Substantially Higher Than in Men. ...
(Date:4/26/2015)... 26, 2015  Ikonopedia announced today that its ... have been selected for use by BelleBridge, which ... and diagnostic examinations. Ikonopedia will showcase its suite ... Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... (SBI Booth #216). BelleBridge is an ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4
... Corporation (NYSE: SGP ) today reported that interim ... (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent ... virus (HCV) genotype 1. In the lead-in arms ... lead-in of PEGINTRON(R) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) ...
... Sciences, Inc. (Nasdaq: CALP ), a leading provider of ... from the United States Food and Drug Administration (FDA) on ... screening and characterization assays for biological drugs. , "We were ... platform to a large group of reviewers. We believe the ...
Cached Medicine Technology:Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 2Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 3Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 4Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 5Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 6Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 7Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 8Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration 2
(Date:4/27/2015)... 27, 2015 The Radiology Business ... members with applied business information and intelligence, is proud ... weekly email newsletter for its more than 2,000 members. ... care legislative news sources in that it is exclusively ... business of radiology. The newsletter is produced in cooperation ...
(Date:4/27/2015)... April 27, 2015 Cambia Health ... has joined its team as Operating Partner within ... focused on investing in and building companies that change ... his new role, Albert will be responsible for accelerating ... so that it is both economically sustainable and person-focused, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Health conscious ... have a first-of-its-kind bakery right on their doorstep, which ... for those on restrictive and low-carbohydrate diets. ... grain, and starch free, and will use only natural ... May 1, 2015, strives to provide specialty food that ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... With the FCPX LUT B&W pack from Pixel ... quickly and easily add desaturated color grades to footage. A ... for modifying an image. The LUT changes every pixel's color ... comes with 60 black and white CUBE LUT files. , ... white films. With the FCPX LUT B&W Loader from ...
Breaking Medicine News(10 mins):Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2
... Security Risks in Exotic Locales , ... Baltimore, MD ... in a down economy should prepare for unexpected medical and security ... vacation. Old and new destinations offering steep discounts may carry risks ...
... kick the habitOLYMPIA, Wash., March 31 A new federal ... cost of a pack of cigarettes by 62 cents. Public ... to quit smoking. The Department of Health,s toll-free Tobacco Quit ... expected loss in sales as more people quit smoking, several ...
... Conference , April 4 - 8 in ChicagoCHICAGO, March 31 ... leading Workforce Management consulting firm, has ... practice dedicated to the Workforce Management (WFM) needs of the ... HIMSS09 , the Healthcare Information and Management ...
... WASHINGTON, March 31 The following is being issued ... 1, at 12:00 noon, D.C. area Pro-life leaders and ... change in HHS regs regarding conscience for health care ... abortion or chemical birth control.A local physician will be ...
... COMPLAINT & ATTORNEY INTERVIEWS AVAILABLE -SEATTLE, March 31 ... tracheal tube clogged with mucous causing oxygen loss and ... Aldercrest Health & Rehabilitation Center in Edmonds, Wash., has ... States-based subsidiaries of Canadian Extendicare REIT. Norene McPherson,s 49-year-old ...
... testimony today before the U.S. Senate Committee on Agriculture, ... revise school food nutrition standards so that more nutritious ... federal nutrition standards for foods sold outside of the ... updated since the late 1970s. , ...
Cached Medicine News:Health News:Don't Sacrifice Your Well-being in a Discount Destination 2Health News:Don't Sacrifice Your Well-being in a Discount Destination 3Health News:Federal Tobacco Tax Increase a Good Reason to Quit Smoking 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 3Health News:Elder Abuse Complaint Filed Against Extendicare 2Health News:Elder Abuse Complaint Filed Against Extendicare 3Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 2Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 3
Small, compact and versatile, the CLK-4 light source is compatible with all Olympus fiberscopes and is ideal for the vast majority of routine fiber-endoscopic procedures, especially in the out-patien...
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers. Polyethylene cover....
Medicine Products: